Few characters in literary history have been adapted with more obsessive fervor than the Great Detective, Sherlock Holmes.

Advarra, the market leader in regulatory review solutions and clinical research technology, today announced the launch of Oncology Research Pulse, a new content-driven, thought leadership initiative ...

Sam Srisatta, a 20-year-old Florida college student, spent a month living inside a government hospital here last fall, ...

Gain an edge with David Booth's investing tips, including strategies for finding cheap stocks and understanding market ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Medical announced the appointment of David Pacitti as its new CEO, effective April 14. Pacitti joins Avanos with a distinguished ...

And in the last one-year period, MD has gained 58.2%. As for the stock's trading volume, 751,779.13 shares on average were traded over the last 20 days. Momentum investors don't just pay attention ...

MD is a #1 (Strong Buy) on the Zacks Rank, with a VGM Score of A. Momentum investors should take note of this Medical stock. MD has a Momentum Style Score of A, and shares are up 2.7% over the ...

Avanos Medical named David Pacitti as its next chief executive officer, effective April 14. The medical technology company will pay Pacitti a base salary around $1.1 million and he would be eligible ...

Rajesh Sinha, a Research Analyst at Bonanza, pointed out that today, the Indian stock market wrapped up a tumultuous session with mixed results across various sectors. The IT sector weighed ...